OTC: EKTAF - Elekta AB (publ)

Rentabilität für sechs Monate: -29.92%
Dividendenrendite: +1.05%
Sektor: Healthcare

Aktionsplan Elekta AB (publ)


Über das Unternehmen Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

weitere details
It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета sek
Див.доход ао 2.08
Дивиденд ао 0.2275
Сайт https://elekta.com
Цена ао 5.69
Preisänderung pro Tag: 0% (4.66)
Preisänderung pro Woche: +2.64% (4.54)
Preisänderung pro Monat: -16.93% (5.61)
Preisänderung über 3 Monate: -14.34% (5.44)
Preisänderung über sechs Monate: -29.92% (6.65)
Preisänderung pro Jahr: -38.36% (7.56)
Preisänderung über 3 Jahre: -66.71% (14)
Preisänderung über 5 Jahre: -45.24% (8.51)
Preisänderung seit Jahresbeginn: -17.52% (5.65)

Unterschätzung

Name Bedeutung Grad
P/S 1.74 8
P/BV 2.93 6
P/E 24.24 6
EV/EBITDA 10.97 7
Gesamt: 6.13

Effizienz

Name Bedeutung Grad
ROA, % 4.23 1
ROE, % 12.7 4
Gesamt: 3.83

Dividenden

Name Bedeutung Grad
Div yield, % 1.05 2.63
DSI 0.8571 8.57
Gesamt: 4.01

Pflicht

Name Bedeutung Grad
Debt/EBITDA 2.21 6
Gesamt: 6.2

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 24.09 4
Rentabilität Ebitda, % 2.18 1
Rentabilität EPS, % 19.99 3
Gesamt: 4.4



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Laurent Leksell Founder & Chairman 1.64M 1952 (73 Jahr)
Mr. Gustaf Salford President & CEO 14.62M 1977 (48 Jahre)
Mr. Tobias Hagglov Chief Financial Officer N/A 1978 (47 Jahre)
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel N/A 1966 (59 Jahre)
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs N/A
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer N/A 1985 (40 Jahre)
Mr. John Lapré President of Brachy & Neuro Solutions N/A 1964 (61 Jahr)
Mr. Maurits Wolleswinkel President of Linac & Software Solutions N/A 1971 (54 Jahr)
Mr. Habib Nehme Chief Commercial Officer N/A 1964 (61 Jahr)
Mr. Peter Nyquist Head of Investor Relations N/A 1965 (60 Jahre)

Adresse: Sweden, Stockholm, Hagaplan 4 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://elekta.com